心脏磁共振检测到的多发性心肌瘢痕对ST段抬高型心肌梗死患者的影响
本研究在704例ST段抬高型心肌梗死患者中于直接经皮冠状动脉介入治疗(PCI)后1天及3个月时行心脏磁共振检查,以晚期钆增强评估心肌瘢痕。3个月时59例(8.4%)存在多发性瘢痕,多发性瘢痕与全因死亡及心力衰竭住院复合终点风险独立相关(风险比2.7,95%置信区间1.1至6.8,p=0.037)。
要点
- ST段抬高型心肌梗死患者中8.4%在3个月时存在多发性瘢痕,最常见原因为非罪犯心肌的慢性瘢痕。
- 多发性瘢痕定义为位于不同冠状动脉供血区域的瘢痕。
- 多发性瘢痕与全因死亡及心力衰竭住院复合终点风险独立相关(风险比2.7)。
核心结论
- ST段抬高型心肌梗死患者中8.4%存在多发性瘢痕,且与长期发病和死亡风险增加独立相关;心脏磁共振上的多发性心肌瘢痕可能作为ST段抬高型心肌梗死后患者风险分层的有用工具。
研究设计与样本
- 在704例ST段抬高型心肌梗死患者中,于直接经皮冠状动脉介入治疗(PCI)后1天及3个月时行心脏磁共振检查,以晚期钆增强评估心肌瘢痕,T2加权技术用于区分急性与慢性梗死,多发性瘢痕定义为位于不同冠状动脉供血区域的瘢痕。
关键影像表现/征象
- 心脏磁共振晚期钆增强显示心肌瘢痕,T2加权技术用于区分急性与慢性梗死。
- 多发性瘢痕定义为瘢痕位于不同冠状动脉供血区域。
- 3个月时59例(8.4%)存在多发性瘢痕。
- 多发性瘢痕中最常见原因为非罪犯心肌的慢性瘢痕。
- 多发性罪犯病变见于7例(1%),随访期间出现第二非罪犯瘢痕见于10例(1.4%)。
诊断标准与关键数值
- 多发性瘢痕定义为晚期钆增强显示的瘢痕位于不同冠状动脉供血区域。
- 多发性瘢痕与全因死亡及心力衰竭住院复合终点的风险比2.7(95%置信区间1.1至6.8,p=0.037),评估时间点为39个月(四分位距31至48个月)。
临床应用与阅片要点
- 心脏磁共振晚期钆增强可用于识别ST段抬高型心肌梗死后的多发性心肌瘢痕。
- 多发性瘢痕的存在可能作为ST段抬高型心肌梗死后患者风险分层的工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study investigated the incidence and long-term prognostic importance of multiple myocardial scars in cardiac magnetic resonance (CMR) in a large contemporary cohort of patients with ST-segment elevation myocardial infarction (STEMI).
BACKGROUND: Patients presenting with STEMI may have multiple infarctions/scars caused by multiple culprit lesions, previous myocardial infarction (MI) or procedure-related MI due to nonculprit interventions. However, the incidence, long-term prognosis, and distribution of causes of multiple myocardial scars remain unknown.
METHODS: CMR was performed in 704 patients with STEMI 1 day after primary percutaneous coronary intervention (PCI) and again 3 months later. Myocardial scars were assessed by late gadolinium enhancement (LGE). T2-weighted technique was used to differentiate acute from chronic infarctions. The presence of multiple scars was defined as scars located in different coronary territories. The combined endpoints of all-cause mortality and hospitalization for heart failure were assessed at 39 months (interquartile range [IQR]: 31 to 48 months).
RESULTS: At 3 months, 59 patients (8.4%) had multiple scars. Of these, multiple culprits in STEMI were detected in 7 patients (1%), and development of a second nonculprit scar at follow-up occurred in 10 patients (1.4%). The most frequent cause of multiple scars was a chronic scar in the nonculprit myocardium. The presence of multiple scars was independently associated with an increased risk of all-cause mortality and hospitalization for heart failure (hazard ratio: 2.7; 95% confidence interval: 1.1 to 6.8; p = 0.037).
CONCLUSIONS: Multiple scars were present in 8.4% of patients with STEMI and were independently associated with an increased risk of long-term morbidity and mortality. The presence of multiple myocardial scars on CMR may serve as a useful tool in risk stratification of patients following STEMI. (DANish Study of Optimal Acute Treatment of Patients With ST-elevation Myocardial Infarction [DANAMI-3]; NCT01435408) (Primary PCI in Patients With ST-elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization [PRIMULTI]; NCT01960933).
引用
- Ekström K, Nepper-Christensen L, Ahtarovski KA, et al. Impact of Multiple Myocardial Scars Detected by CMR in Patients Following STEMI. JACC Cardiovasc Imaging. 2019. PMID: 31005537. doi:10.1016/j.jcmg.2019.01.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。